Enter B and W: two new meningococcal vaccine programmes launched
about
Emerging experience with meningococcal serogroup B protein vaccines.Does post-implementation vaccine effectiveness data support pre-implementation predictions of 4CMenB utility?The importance of surveillance: Group W meningococcal disease outbreak response and control in England.Short-term changes in the health state of children with group B meningococcal disease: A prospective, national cohort studyA Meningococcal Outer Membrane Vesicle Vaccine Incorporating Genetically Attenuated Endotoxin Dissociates Inflammation from Immunogenicity.Frequent capsule switching in 'ultra-virulent' meningococci - Are we ready for a serogroup B ST-11 complex outbreak?The next chapter for group B meningococcal vaccines.Presentation with gastrointestinal symptoms and high case fatality associated with group W meningococcal disease (MenW) in teenagers, England, July 2015 to January 2016.Novel approaches to Neisseria meningitidis vaccine design.Validation of two algorithms for managing children with a non-blanching rash.Meningococcal W outbreak.Community-acquired bacterial meningitis.Meningococcal arthritis and myopericarditis: a case report.4CMenB vaccine effectiveness: reasons for optimism.Challenges and opportunities for Meningococcal vaccination in the developing world.Prevalence and serogroup changes of Neisseria meningitidis in South Korea, 2010-2016.Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010-2016.
P2860
Q30234958-D758A6D2-BB17-4E93-9682-38EA995F4DF7Q30235138-A5FCED88-291E-4513-A2FA-BF8794AAE091Q30245411-15C15F2A-BD72-4041-9E66-B78391E2726BQ33703622-4BE8B271-FE13-4D09-8DA9-3BFE9D7B8F96Q37483629-F7620DB1-075D-4F1F-A4B2-785983B36F05Q38674983-16457AFA-7E21-41DE-9372-E1EC42709BA9Q38677309-42A3A836-EF1B-4EBB-9D9E-AEE0C8D0E16BQ38795433-100E32C0-A54C-4002-9C16-1DC6C3A3A90BQ39215403-F180F55D-F3BD-4275-85E4-DCB6958CC624Q39914565-162FF6BE-2F45-4DBF-A73D-92C72A277FD6Q40657029-E9CD46BE-44ED-46E5-98F3-9F17349E8572Q43568749-A8D2944C-A7F6-409C-8F3F-C352E3C6547FQ47097240-C8F6C1B6-5A88-47A8-B346-0FDCA2A5C8CEQ47352260-BD44CB56-9AA7-4A50-B6F9-3A2F4B21EE3EQ49377063-16536AE0-0272-4420-8662-07E6853DA4DEQ54956641-C2AF4645-B325-4813-BAE0-21DABEEDDF66Q55154523-74297FF4-8734-4C1D-A9B9-8916C396844B
P2860
Enter B and W: two new meningococcal vaccine programmes launched
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Enter B and W: two new meningococcal vaccine programmes launched
@ast
Enter B and W: two new meningococcal vaccine programmes launched
@en
Enter B and W: two new meningococcal vaccine programmes launched
@nl
type
label
Enter B and W: two new meningococcal vaccine programmes launched
@ast
Enter B and W: two new meningococcal vaccine programmes launched
@en
Enter B and W: two new meningococcal vaccine programmes launched
@nl
prefLabel
Enter B and W: two new meningococcal vaccine programmes launched
@ast
Enter B and W: two new meningococcal vaccine programmes launched
@en
Enter B and W: two new meningococcal vaccine programmes launched
@nl
P2093
P2860
P1476
Enter B and W: two new meningococcal vaccine programmes launched
@en
P2093
Andrew J Pollard
Andrew Riordan
John M Watson
Ray Borrow
P2860
P356
10.1136/ARCHDISCHILD-2015-308928
P407
P577
2016-01-01T00:00:00Z